![]() |
市場調查報告書
商品編碼
1847161
全球肩關節重組器材市場:市場規模、佔有率和趨勢分析(2025-2031 年)Shoulder Reconstruction Devices Market Size, Share & Trends Analysis | Global | 2025-2031 | Includes: Total Shoulder Implants, Reversed Shoulder Implants, and 4 more |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
全球肩部重建器材市場預計到 2024 年將超過 21 億美元,到 2031 年將超過 34 億美元,年複合成長率為 6.8%。
本報告涵蓋全肩關節置換術植入、反向肩關節關節重建植入、髖置換術植入、肩關節重新置換關節移植、肩關節翻修植入以及肱骨近端鋼板和螺絲。報告量化了銷量、平均售價、市場規模、成長率和企業市場占有率。此外,報告還分析了市場促進因素和限制因素、近期併購活動、產品系列和競爭動態。報告提供截至2021年的歷史數據,並預測至2031年。
數位化工具正在提升手術室的精準度。由於肩關節手術的預後取決於髁突的精確定位和關節生物力學的恢復,因此3D規劃軟體、導航系統和術中定位輔助器具正被日益廣泛地應用。這些工具能夠幫助外科醫生獲得更可預測的手術結果,並使他們更有信心採用新一代系統。
市場概覽
隨著肩關節重建技術的日益成熟,全球對這項手術的需求持續成長,不再局限於早期接受者。反向肩關節置換術正從最初用於治療肩迴旋肌損傷和複雜退化性疾病的特殊選擇,逐漸發展成為常規治療方案。同時,它在重新置換手術中也扮演著越來越重要的角色,增加了手術量,並推動了植入和器械的持續升級。
解剖型全肩關節關節重建仍是一項核心手術。外科醫生正在用無柄模組化無柄更好地保護骨骼、簡化手術視野,並使未來的重新置換更加便捷。在創傷治療中,肱骨近端關節置換術仍然是整形外科量較大的項目,肩關節重建與骨折治療密切相關,即使在混合診療模式下也是如此。
市場格局也受到工作流程變化的影響。越來越多的手術轉移到門診手術中心,在這些中心,可預測的術前準備、更短的麻醉時間和更快的出院速度是首要考慮因素。這種轉變促使人們青睞精簡的器械、清晰的定位導向器和可重複的手術技術,進而縮短手術時間。隨著各專案培訓和通訊協定的標準化,能夠提供包含規劃、導向器和可調整結構的完整平台的供應商正在獲得競爭優勢。
價格壓力持續存在,尤其是在北美以外的競標。儘管如此,持續的臨床需求、老化且活躍的患者群體,以及外科醫生對逆向和無柄系統的日益熟悉,都將支撐市場在2031年之前保持穩定成長。
市場促進因素
反向肩關節關節重建植入的優點和多功能性
反向肩關節置換術現已成為肩關節重建手術的基石。它可用於治療肩迴旋肌損傷、複雜的骨關節炎,並在許多挽救生命的手術中發揮作用。其在初次手術和翻修手術中的多功能性,使其成為解剖復位難以成功時的首選方案。適應症的不斷擴大和療效的持續穩定,也推動了反向肩關節置換術市場的發展。
在高成長地區增加手術量
北美是以金額為準最大的市場,但亞太、東歐和中東地區的複合成長速度最快。這些地區正加大對外科醫生培訓和醫療設施升級的投入,以推動醫療計畫從單純的創傷救治轉向擇期關節置換術。隨著病例數的多樣化和植入熟悉度的提高,肩關節重建正逐漸成為標準整形外科治療的一部分,而不再是需要轉診的專科手術。
轉向無柄和重新置換系統
無柄和模組化植入正迅速取代傳統的有柄設計。這些系統最大限度地減少了骨切除量,縮短了手術時間,並在解剖結構或骨質量與預期不符時提供了術中靈活性。與重新置換植入物的兼容性使得初次治療和重新置換治療部分可以進行策略性重疊,從而鼓勵醫院採用單一平台進行標準化。
數位化規劃和術中對準
術前3D規劃明確了目標假體的角度、傾斜度和偏移。導航和對準輔助功能有助於將規劃付諸實踐,尤其是在關節鏡手術中,微小的偏差都可能影響假體的穩定性和磨損。這種從規劃到植入全程嚴格把控的概念,提高了手術的可靠性,減少了不同團隊之間的差異,最終帶來了更好的治療效果。
翻修手術的成熟之路
隨著初次手術量的增加,重新置換量也隨之增加。能夠實現解剖復位到反向復位,並支援使用常用器械進行分期重建的系統,具有臨床和經濟優勢。隨著越來越多的中心擴大重新置換能力,對相容的組件、增強裝置和約束裝置的需求也隨之增加。
市場限制
由於競標制度,平均售價加速下降
公開競標和綜合採購都非常重視價格。尤其是在北美以外的地區,這種逐年上漲的平均售價壓力限制了高階創新產品以全額價值定價的能力。供應商必須在功能和價格之間取得平衡,才能在競標激烈的地區保持競爭力。
置換術的結構減少
隨著外科醫師轉向採用無柄解剖型和反向假體,這些假體具有更可靠的固定效果和更廣泛的適應症,置換術的數量持續下降。曾接受相關訓練且願意進行髖置換術的外科醫師人數減少,導致該領域市佔率逐年下降。
取得重新置換手術基礎設施的機會不平等
重新置換手術依賴專業團隊、先進的影像技術和全面的復健治療。許多醫療系統,尤其是在新興市場,難以持續取得這些資源。因此,在臨床需求存在但相關服務體系尚未完善的地區,重新置換植入往往被忽略。
市場和數據覆蓋範圍
醫療機構包括醫院、整形外科專科中心和門診手術中心。
目標市場及區隔
肩關節重建器材市場
全肩關節關節移植
反向肩關節關節重建植入
股骨頭置換術植入
肩關節表面置換關節移植
肩關節重新置換關節移植
肱骨近端鋼板和螺絲
針對每個設備類別,我們分析其銷售、平均售價和市場價值,並提供 2031 年的歷史趨勢和成長預測。
競爭分析
2024年,Zimmer Biomet在肩關節重建器材市場佔有領先地位。其市場地位得益於其全面的產品組合,涵蓋解剖型關節重建和反向關節重建,而其核心產品是Comprehensive®肩關節系統。該平台的模組化設計支援術中決策,使外科醫生能夠根據不同的解剖結構客製化植入,並確保從初次手術到重新置換手術的連續性。 Zimmer Biomet早期參與反向肩關節手術以及持續的設計改進,贏得了不同醫療機構外科醫生的長期信賴。
史賽克則排名第二。該公司將資源集中於反向肩關節置換術,並根據肩迴旋肌損傷和老年患者的需求調整藍圖。收購托尼爾後,反向肩關節置換術在美國和歐洲市場站穩了腳步。此後,史賽克進一步簡化了手術器械,提高了術中靈活性。該公司在髖置換術術、相關器材以及某些重新置換器材領域的投入有限,反映了其有意瞄準臨床需求最旺盛、成長最快、收入最高的領域。
DePuy Synthes排名第三。 DePuy Synthes的優點在於創傷和肩關節置換術,尤其是肱骨近端關節置換術。 DePuy Synthes將肩關節置換術融入更廣泛的創傷治療體系,利用創傷外科醫師廣泛使用的器械和技術。這建構了一條涵蓋骨折治療到擇期肩關節重建的臨床產品線。該公司在重新置換和置換術的業務有限,在綜合關節置換中心的覆蓋範圍也有限,但它非常適合高創傷救治中心。
競爭的焦點依然集中在產品的多功能性、儀器效率和數位化規劃。能夠簡化從規劃到植入流程並支援可預測的後續重新置換手術的供應商,將在培訓計畫和大型醫療中心佔優勢。
科技與臨床趨勢
這些趨勢相互促進:規劃改善了植入的選擇,定位輔助工具增強了植入效果,模組化系統為未來的治療保留了選擇餘地,從而實現了更可預測的治療,並支持在各種治療環境中實施。
地區
其涵蓋範圍包括北美、歐洲、亞太地區、拉丁美洲以及中東和非洲。
肩關節重建最大、成長最快的機會在哪裡?
反向、解剖式和無柄系統如何重塑產品策略和訓練路徑。
哪些數位化規劃和術中對準工具越來越受歡迎?它們對治療結果為何如此重要?
競標和定價壓力將如何影響您在北美以外地區的上市策略和產品組合?
修正後的需求預期以及供應商應如何調整其平台和庫存以滿足需求。
到 2031 年,Zimmer Biomet、Stryker 和 DePuy Synthes 將如何擴大市場佔有率?
商業團隊如何因應門診手術中心轉型、流程標準化以及區域外科醫師教育需求?
iData Research 的肩關節重建器械市場報告透過考慮手術流程的模型、定價細節和企業市場占有率分析來回答這些問題。
該報告可用於量化設備類型的需求,規劃新產品發布,設定定價和合約目標,並優先考慮培訓和支援計劃,以加速產品推廣。
目錄
圖表清單
圖表列表
調查方法
全球關稅的影響
肩關節重建器材市場
The global shoulder reconstruction device market was valued at over $2.1 billion in 2024. It is expected to grow at a compound annual growth rate of 6.8 percent to surpass $3.4 billion by 2031.
This report covers total shoulder implants, reversed shoulder implants, hemi shoulder implants, resurfacing shoulder implants, revision shoulder implants, and proximal humerus plates and screws. It quantifies unit sales, average selling prices, market size, growth rates, and company shares and analyzes market drivers and limiters, recent mergers and acquisitions, product portfolios, and competitive dynamics. The study provides historical data to 2021 and forecasts to 2031.
Digital tools are improving precision in the operating room. 3D planning software, navigation systems, and intraoperative alignment aids are gaining use because shoulder outcomes depend on accurate glenoid positioning and restoration of joint biomechanics. These tools support more predictable results and help surgeons adopt next-generation systems with greater confidence.
Market Overview
Global demand for shoulder reconstruction continues to expand as the procedure set matures beyond early adopters. Reverse shoulder arthroplasty has moved from a specialized option to a routine solution for cuff-deficient shoulders and complex degenerative cases. Its role in revision pathways has also grown, which increases addressable volume and supports a stable upgrade cycle for implants and instruments.
Anatomic total shoulder arthroplasty remains a core procedure. Surgeons are replacing older stemmed designs with stemless and modular systems that conserve bone, simplify exposure, and make future revisions more manageable. On the trauma side, proximal humerus plating remains a high-volume category within orthopedics, which keeps shoulder reconstruction connected to fracture care in mixed practice settings.
The market is also shaped by workflow changes. More cases are moving to ambulatory surgery centers where predictable setup, shorter anesthesia times, and faster discharge are priorities. This shift favors streamlined instrumentation, clear alignment guides, and reproducible techniques that reduce operative time. As programs standardize training and protocols, vendors that offer complete platforms with planning, guides, and revision-ready constructs are gaining a competitive edge.
Price pressure continues, especially in tenders outside North America. Even so, sustained clinical need, an aging and active patient population, and wider surgeon familiarity with reverse and stemless systems support steady value growth through 2031.
Market Drivers
Dominance and versatility of reverse shoulder implants
Reverse systems are now the backbone of shoulder reconstruction. They address rotator cuff insufficiency, complex osteoarthritis, and many salvage situations. Their versatility in both primary and revision procedures makes them the default option when anatomic repair is unlikely to succeed. As indications broaden and outcomes remain consistent, reverse procedures continue to anchor market expansion.
Increased procedural volume in high-growth regions
North America is the largest market by value, yet the fastest compound growth is coming from Asia-Pacific, Eastern Europe, and the Middle East. These regions are investing in surgeon training and facility upgrades that move programs from trauma-only service to elective arthroplasty. As caseloads diversify and implant familiarity increases, shoulder reconstruction becomes a standard part of orthopedic offerings rather than a specialized referral.
Shift toward stemless and revision-compatible systems
The replacement of older stemmed designs with stemless and modular implants is accelerating. These systems minimize bone removal, can shorten operative time, and offer intraoperative flexibility when anatomy or bone quality differs from plan. Their compatibility with revision constructs creates strategic overlap between primary and revision segments and encourages hospitals to standardize on a single platform.
Digital planning and intraoperative alignment
Preoperative 3D planning clarifies version, inclination, and offset goals. Navigation and alignment aids help translate plan to execution, especially for glenoid work where small deviations affect stability and wear. This push toward plan-to-implant fidelity improves confidence, reduces variability across teams, and supports positive outcomes that sustain adoption.
Maturing revision pathways
Growing primary volumes naturally lead to more revision procedures. Systems that allow conversion from anatomic to reverse or support staged reconstruction with familiar instruments create clinical and economic advantages. As more centers build revision capacity, the pull for compatible components, augments, and constraint options grows with it.
Market Limiters
Accelerated ASP erosion through tender systems
Public tenders and consolidated procurement place heavy weight on price. This year-over-year ASP pressure, especially outside North America, limits the ability to position premium innovations at full value. Vendors must balance feature sets with affordability to remain competitive in tender-heavy regions.
Structural decline of resurfacing procedures
Resurfacing volumes continue to fall. Surgeons have shifted to stemless anatomic or reverse solutions that deliver reliable fixation and broader indications. With fewer surgeons trained or inclined to perform resurfacing, the segment's share declines further each year.
Uneven access to revision infrastructure
Revision surgery depends on specialized teams, advanced imaging, and comprehensive rehabilitation. Many health systems, especially in emerging markets, lack consistent access to these resources. As a result, revision-oriented implants underpenetrate in settings where the clinical need exists but service lines are still developing.
Market Coverage and Data Scope
Care settings include hospitals, orthopedic specialty centers, and ambulatory surgery centers.
Markets Covered and Segmentation
Shoulder Reconstruction Device Market
Total shoulder implant
Reversed shoulder implant
Hemi shoulder implant
Resurfacing shoulder implant
Revision shoulder implant
Proximal humerus plate and screw
Each device category is analyzed for unit volume, ASP, and market value, with historical trends and forecast growth through 2031.
Competitive Analysis
Zimmer Biomet led the shoulder reconstruction device market in 2024. Its position reflects a comprehensive portfolio across anatomic and reverse arthroplasty with the Comprehensive(R) Shoulder System at the center. The platform's modularity supports intraoperative decisions, allows surgeons to tailor implants to variable anatomy, and provides continuity from primary to revision. Early participation in reverse shoulder and ongoing design refinements have built long-term surgeon loyalty across mixed practice settings.
Stryker held the second-leading position. The company focused resources on reverse shoulder arthroplasty and aligned its roadmap with the needs of rotator cuff-deficient and older patients. The Tornier acquisition provided established reverse designs in the United States and Europe. Stryker has since streamlined instrumentation and enhanced intraoperative flexibility. The company's limited presence in hemi and certain revision constructs reflects a deliberate choice to target high-growth, high-margin segments where clinical demand is strongest.
DePuy Synthes ranked third. Its strength sits at the intersection of trauma and shoulder, most notably proximal humerus plating. DePuy Synthes has integrated shoulder arthroplasty into a broader trauma ecosystem, leveraging widely used hardware and techniques among trauma surgeons. This creates a clinical pipeline from fracture management to elective shoulder reconstruction. The company's lower visibility in revision and resurfacing narrows its reach in comprehensive arthroplasty centers but fits well in trauma-heavy institutions.
Competition continues to focus on construct versatility, instrument efficiency, and digital planning. Vendors that simplify the move from plan to implant and support predictable conversion to revision hold advantages in training programs and high-volume centers.
Technology and Practice Trends
These trends reinforce each other. Planning improves implant selection, alignment aids improve execution, and modular systems preserve options for future care. The result is a more predictable experience that supports adoption across diverse care settings.
Geography
This edition provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
Where are the largest and fastest-growing opportunities within shoulder reconstruction.
How are reverse, anatomic, and stemless systems reshaping product strategies and training paths.
Which digital planning and intraoperative alignment tools are gaining traction and why they matter for outcomes.
How do tender systems and pricing pressure affect launch strategies and portfolio mix outside North America.
What is the outlook for revision demand, and how should vendors align platforms and inventory to support it.
Which companies lead today, and how are Zimmer Biomet, Stryker, and DePuy Synthes positioning for share gains through 2031.
How can commercial teams plan for ASC migration, procedural standardization, and surgeon education needs across regions.
The Shoulder Reconstruction Device Market Report from iData Research answers these questions with procedure-aware models, pricing detail, and company share analysis.
Use it to quantify demand by device type, plan new product entries, set pricing and contracting targets, and prioritize training and support programs that speed adoption.
Table Of Contents
List Of Figures
List Of Charts
Research Methodology
Impact Of Global Tariffs
Shoulder Reconstruction Device Market